FINWIRES · TerminalLIVE
FINWIRES

RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62

By

Bio-Techne (TECH) has an average rating of hold and mean price target of $70.33, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles